SE432593B - Forfarande for framstellning av 5-hydroxi-2-(3-oxo-1-oktenyl)-1-cyklopentanettiksyra-gamma-lakton-derivat - Google Patents
Forfarande for framstellning av 5-hydroxi-2-(3-oxo-1-oktenyl)-1-cyklopentanettiksyra-gamma-lakton-derivatInfo
- Publication number
- SE432593B SE432593B SE7607875A SE7607875A SE432593B SE 432593 B SE432593 B SE 432593B SE 7607875 A SE7607875 A SE 7607875A SE 7607875 A SE7607875 A SE 7607875A SE 432593 B SE432593 B SE 432593B
- Authority
- SE
- Sweden
- Prior art keywords
- cyclopentanetic
- lamon
- derivate
- octenyl
- oxo
- Prior art date
Links
- -1 3-OXO-1-OCTENYL Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/64—Acyl halides
- C07C57/72—Acyl halides containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/595,869 US4026909A (en) | 1975-07-14 | 1975-07-14 | Cis-13-PGF2.sub.α analogs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7607875L SE7607875L (sv) | 1977-01-15 |
| SE432593B true SE432593B (sv) | 1984-04-09 |
Family
ID=24385022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7607875A SE432593B (sv) | 1975-07-14 | 1976-07-09 | Forfarande for framstellning av 5-hydroxi-2-(3-oxo-1-oktenyl)-1-cyklopentanettiksyra-gamma-lakton-derivat |
Country Status (14)
| Country | Link |
|---|---|
| US (24) | US4026909A (es) |
| JP (1) | JPS5210243A (es) |
| AU (1) | AU500639B2 (es) |
| BE (1) | BE844105A (es) |
| CA (1) | CA1064483A (es) |
| CH (1) | CH625797A5 (es) |
| DE (1) | DE2630879A1 (es) |
| FR (1) | FR2317915A1 (es) |
| GB (1) | GB1554022A (es) |
| HU (1) | HU177771B (es) |
| MX (1) | MX3343E (es) |
| NL (1) | NL7607728A (es) |
| SE (1) | SE432593B (es) |
| ZA (1) | ZA763765B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4190587A (en) * | 1973-08-06 | 1980-02-26 | Hoffmann-La Roche Inc. | 4-(3-Oxo-4-trifluoromethyl-1-octenyl)-2-oxo-2H-cyclopenta[b]furans |
| US4237276A (en) * | 1974-06-18 | 1980-12-02 | Hoffmann-La Roche Inc. | Bicyclic lactone intermediates for 16-substituted prostaglandins |
| US4183870A (en) * | 1974-01-26 | 1980-01-15 | May & Baker Limited | Cyclopentane derivatives |
| US4123456A (en) * | 1974-11-07 | 1978-10-31 | American Cyanamid Company | Novel 11-hydroxy-9-keto-5,6-cis-13,14-cis-prostadienoic acid derivatives |
| US4016184A (en) * | 1975-09-17 | 1977-04-05 | The Upjohn Company | 9-Deoxy-9,10-didehydro-PGD1 compounds |
| US4207227A (en) * | 1976-12-03 | 1980-06-10 | Bayer Aktiengesellschaft | Stable suspensions of inorganic fillers in organic polyhydroxyl compounds |
| DE2739620A1 (de) * | 1977-09-02 | 1979-03-08 | Bayer Ag | Stabile suspensionen anorganischer fuellstoffe in organischen polyhydroxylverbindungen |
| US4312810A (en) * | 1978-11-22 | 1982-01-26 | The Upjohn Company | 2,5-Inter-o-phenylene-3,4-dinor-5,9α-epoxy-9-deoxy-PGF1 compounds |
| JPH0382248U (es) * | 1989-12-12 | 1991-08-22 | ||
| US5262437A (en) * | 1990-12-10 | 1993-11-16 | Allergan, Inc. | Homo-prostaglandin derivatives as ocular hypotensives |
| EP0857718B1 (en) * | 1996-06-10 | 2002-08-14 | Sucampo AG | Endothelin antagonist |
| US7842727B2 (en) | 2001-03-27 | 2010-11-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| US7312247B2 (en) | 2001-03-27 | 2007-12-25 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| US6495719B2 (en) | 2001-03-27 | 2002-12-17 | Circagen Pharmaceutical | Histone deacetylase inhibitors |
| US8026280B2 (en) | 2001-03-27 | 2011-09-27 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| CA2486303C (en) | 2002-05-22 | 2013-04-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors based on alpha-ketoepoxide compounds |
| CA2506504A1 (en) | 2002-11-20 | 2004-06-03 | Errant Gene Therapeutics, Llc | Treatment of lung cells with histone deacetylase inhibitors |
| US8487147B2 (en) * | 2010-03-01 | 2013-07-16 | Syed Tajammul Hussain | Nano-catalyst for fast track bio-diesel production from non-edible oils |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3959346A (en) * | 1969-03-14 | 1976-05-25 | The Upjohn Company | Racemic prostaglandins of the 2-series and analogs thereof |
| JPS503362B1 (es) * | 1970-06-10 | 1975-02-04 | ||
| DE2317019A1 (de) * | 1972-04-27 | 1973-11-08 | Upjohn Co | Neue 4,5-didehydro-prostaglandine |
| US3816383A (en) * | 1972-05-01 | 1974-06-11 | Nat Petro Chem | Separation of olefin polymers |
| US4011262A (en) * | 1972-07-13 | 1977-03-08 | Pfizer Inc. | 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series |
| US4046801A (en) * | 1972-07-18 | 1977-09-06 | Syntex (U.S.A.) Inc. | 13-Cis prostaglandin derivatives |
| US3867377A (en) * | 1972-07-18 | 1975-02-18 | Syntex Inc | Method of making 13-cis prostaglandin derivatives |
| US3873607A (en) * | 1972-07-24 | 1975-03-25 | American Cyanamid Co | 3-Oxa(and thia) 11-deoxy PGE |
| US3933899A (en) * | 1972-10-30 | 1976-01-20 | The Upjohn Company | PGE2 -oxa-phenylene compounds |
| US3914282A (en) * | 1973-01-16 | 1975-10-21 | Upjohn Co | Prostaglandin E{HD 1{B , F{HD 1{B , and A{HD 1 {B analogs |
| US3932479A (en) * | 1973-04-27 | 1976-01-13 | American Cyanamid Company | Lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates |
| US3962293A (en) * | 1973-07-20 | 1976-06-08 | The Upjohn Company | 13,14-Dihydro-16-fluoro prostaglandin F1 |
| US3932463A (en) * | 1974-06-03 | 1976-01-13 | American Cyanamid Company | 11-Deoxy-13-dihydro-prostaglandin-9-ketals |
| US3970685A (en) * | 1974-06-05 | 1976-07-20 | Syntex (U.S.A.) Inc. | (DL)-13-Substituted sulfinyl-prostaglandin-like compounds |
-
1975
- 1975-07-14 US US05/595,869 patent/US4026909A/en not_active Expired - Lifetime
-
1976
- 1976-05-27 CA CA253,511A patent/CA1064483A/en not_active Expired
- 1976-06-15 MX MX000316U patent/MX3343E/es unknown
- 1976-06-21 GB GB25672/76A patent/GB1554022A/en not_active Expired
- 1976-06-23 ZA ZA763765A patent/ZA763765B/xx unknown
- 1976-06-25 AU AU15281/76A patent/AU500639B2/en not_active Expired
- 1976-07-08 JP JP51080434A patent/JPS5210243A/ja active Pending
- 1976-07-09 DE DE19762630879 patent/DE2630879A1/de not_active Withdrawn
- 1976-07-09 SE SE7607875A patent/SE432593B/xx unknown
- 1976-07-13 FR FR7621528A patent/FR2317915A1/fr active Granted
- 1976-07-13 NL NL7607728A patent/NL7607728A/xx not_active Application Discontinuation
- 1976-07-13 HU HU76UO121A patent/HU177771B/hu unknown
- 1976-07-13 CH CH899276A patent/CH625797A5/de not_active IP Right Cessation
- 1976-07-14 BE BE168892A patent/BE844105A/xx not_active IP Right Cessation
-
1977
- 1977-03-03 US US05/774,083 patent/US4118581A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,085 patent/US4122100A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,185 patent/US4122102A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,078 patent/US4129582A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,086 patent/US4122103A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,178 patent/US4122101A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,079 patent/US4118578A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,084 patent/US4120878A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,081 patent/US4118580A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,186 patent/US4161605A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,177 patent/US4122284A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,082 patent/US4085271A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,181 patent/US4119787A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,179 patent/US4127724A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,080 patent/US4118579A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,183 patent/US4119651A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,184 patent/US4127726A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,180 patent/US4127725A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,176 patent/US4127723A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,182 patent/US4122283A/en not_active Expired - Lifetime
- 1977-03-03 US US05/774,077 patent/US4088663A/en not_active Expired - Lifetime
-
1978
- 1978-05-08 US US05/904,185 patent/US4163107A/en not_active Expired - Lifetime
- 1978-05-08 US US05/904,183 patent/US4161606A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE429970B (sv) | Forfarande for framstellning av glukopyranosido-1,6-mannit | |
| SE7610422L (sv) | Forfarande for framstellning av pyrimidinderivat | |
| SE434049B (sv) | Forfarande for framstellning av 1,4-dihydropyridinderivat | |
| SE445923B (sv) | Forfarande for framstellning av glukosaminderivat | |
| SE431456B (sv) | Analogiforfarande for framstellning av kondenserade kinazolonderivat | |
| SE434394B (sv) | Analogiforfarande for framstellning av kinolonalkansyraderivat | |
| SE431089B (sv) | Forfarande for framstellning av beta-metyltio-propionaldehyd | |
| SE432593B (sv) | Forfarande for framstellning av 5-hydroxi-2-(3-oxo-1-oktenyl)-1-cyklopentanettiksyra-gamma-lakton-derivat | |
| SE434057B (sv) | Forfarande for framstellning av nya rifamycinforeningar | |
| SE403380B (sv) | Forfarande for framstellning av 17alfa-estrar-21-halogenpregnaner | |
| SE412066B (sv) | Forfarande for framstellning av famakologiskt verksamma tienodiazinderivat | |
| SE430336B (sv) | Forbettrat forfarande for framstellning av amoxicillinfrihydrat | |
| SE433745B (sv) | Forfarande for framstellning av tetrahydroisokinolinderivat | |
| SE7613973L (sv) | Forfarande for framstellning av pappersmassa | |
| SE7613768L (sv) | Forfarande for framstellning av penicillinestrar | |
| SE423390B (sv) | Foerfarande foer framstaellning av eburnameninderivat | |
| SE428296B (sv) | Analogiforfarande for framstellning av substituerade difonylsulfider | |
| SE422205B (sv) | Forfarande for framstellning av 1-karbamoyl-5-fluoruracil derivat | |
| SE423902B (sv) | Forfarande for framstellning av purinderivat | |
| NO147672C (no) | Analogifremgangsmaate for fremstilling av n-aryl-n-(1-l1-4-piperidinyl)-arylacetamider | |
| SE423025B (sv) | Forfarande for framstellning av proteinfilameter | |
| SE7606890L (sv) | Forfarande for framstellning av polyacetovinyldispersioner | |
| SE433210B (sv) | Forfarande for framstellning av ny cyklohexylfenylderivat | |
| SE439159B (sv) | Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat | |
| SE420093B (sv) | Forfarande for framstellning av 5-fenyl-2-furamidoximer |